Skip to content

CooperVision is now accepting submissions for its 2023 Science and Technology Awards

Published: 12.05.2023

CooperVision is now accepting submissions for its 2023 Science and Technology Awards.

The program fosters partnerships between recipients and CooperVision scientists to explore new dimensions in vision care, with the goal of translating innovative ideas into practical solutions.

Interested applicants must submit a letter of intent before June 23, 2023.

Additional Information may be found at :

The key focus areas for 2023 are:

  • Understanding Childhood Myopia Development:
    • Pathogenesis, mechanisms, and risk factors
  • Technologies to Prevent Myopia Onset, including:
    • Prophylactic technologies
    • Proposals for glasses, contact lenses, interactive, and combination therapies
  • Strategies to prevent the development of symptomatology in new contact lens wearers, with emphasis on:
    • Diagnosis and early intervention therapies for new lens wearers
    • Understanding biochemical changes in newly fitted contact lens wearers over time
    • Controlled release technologies for delivery of beneficial agents, as well as approaches to improve moisture retention
  • Impact of Artificial Intelligence (AI) on Contact Lens Fitting and Diagnostics, including:
    • ChatGPT , Bard, etc. – Applications for Optometry and Orthokeratology (Ortho-K)

Award Types

Research proposals may span proof-of-concept through translational stages. For this purpose, two types of awards are offered:

  • CooperVision Seedling Award
    The CooperVision Seedling Award is intended to incentivize collaborations with CooperVision in a new research area for a one-year period. The maximum total cash amount for a CooperVision seedling is $100,000.
  • CooperVision Translational Research Award
    The CooperVision Translational Research Award is a multi-year award for a substantive translational research project with funding over two years, totaling up to $400,000.

Applicant Eligibility

Any researcher with Principal Investigator (PI) status holding a MD, OD, or PhD is eligible to apply. Applicants, such as postdoctoral fellows, with a waiver of PI status must submit appropriate documentation before funding can be received.